187 related articles for article (PubMed ID: 30223802)
1. EXclusion of non-Involved uterus from the Target Volume (EXIT-trial): an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques.
Vandecasteele K; Tummers P; Van Bockstal M; De Visschere P; Vercauteren T; De Gersem W; Denys H; Naert E; Makar A; De Neve W
BMC Cancer; 2018 Sep; 18(1):898. PubMed ID: 30223802
[TBL] [Abstract][Full Text] [Related]
2. Exclusion of non-Involved uterus from the target volume (EXIT-trial): An individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques followed by completion surgery.
Van Damme A; Tummers P; De Visschere P; Van Dorpe J; Van de Vijver K; Vercauteren T; De Gersem W; Denys H; Naert E; Makar A; De Neve W; Vandecasteele K
Clin Transl Radiat Oncol; 2024 Jul; 47():100793. PubMed ID: 38798749
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
Lee SW; Lee SH; Kim J; Kim YS; Yoon MS; Jeong S; Kim JH; Lee J; Eom KY; Jeong BK; Sung SY; Lee SJ; Lee JH
Gynecol Oncol; 2017 Nov; 147(2):334-339. PubMed ID: 28935271
[TBL] [Abstract][Full Text] [Related]
5. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
6. Post radiation hysterectomy in locally advanced cervical cancer: Outcomes and dosimetric impact.
Mazeron R; Gouy S; Chargari C; Rivin Del Campo E; Dumas I; Mervoyer A; Genestie C; Bentivegna E; Balleyguier C; Pautier P; Morice P; Haie-Meder C
Radiother Oncol; 2016 Sep; 120(3):460-466. PubMed ID: 27492204
[TBL] [Abstract][Full Text] [Related]
7. The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery.
Valentini AL; Miccò M; Gui B; Giuliani M; Rodolfino E; Telesca AM; Pasciuto T; Testa A; Gambacorta MA; Zannoni G; Rufini V; Giordano A; Valentini V; Scambia G; Manfredi R
Eur Radiol; 2018 Jun; 28(6):2425-2435. PubMed ID: 29318432
[TBL] [Abstract][Full Text] [Related]
8. Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images.
Erbay G; Onal C; Karadeli E; Guler OC; Arica S; Koc Z
Acta Radiol; 2017 Apr; 58(4):481-488. PubMed ID: 27445314
[TBL] [Abstract][Full Text] [Related]
9. Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy.
Zhao B; Cao K; Li XT; Zhu HT; Sun YS
BMC Cancer; 2019 Nov; 19(1):1115. PubMed ID: 31729974
[TBL] [Abstract][Full Text] [Related]
10. What to expect from immediate salvage hysterectomy following concomitant chemoradiation and image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P; Chargari C; Bouaita R; Dumas I; Farha G; Kamsu-Kom L; Rivin Del Campo E; Martinetti F; Morice P; Haie-Meder C; Mazeron R
Cancer Radiother; 2015 Dec; 19(8):710-7. PubMed ID: 26508320
[TBL] [Abstract][Full Text] [Related]
11. Completion surgery after chemoradiotherapy for cervical cancer - is there a role? UK Cancer Centre experience of hysterectomy post chemo-radiotherapy treatment for cervical cancer.
Platt SL; Patel A; Humphrey PJ; Al-Booz H; Bailey J
J Obstet Gynaecol; 2019 Jan; 39(1):68-73. PubMed ID: 30230397
[TBL] [Abstract][Full Text] [Related]
12. Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer.
Ho JC; Fang P; Cardenas CE; Mohamed ASR; Fuller CD; Allen PK; Bhosale PR; Frumovitz MM; Jhingran A; Klopp AH
Radiother Oncol; 2019 Jun; 135():58-64. PubMed ID: 31015171
[TBL] [Abstract][Full Text] [Related]
13. MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial.
Kang HB; Kim SH; Lee JH; Lee HC; Kang NK; Lee JH
Int J Clin Oncol; 2024 May; 29(5):620-628. PubMed ID: 38530569
[TBL] [Abstract][Full Text] [Related]
14. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer.
Haack S; Pedersen EM; Jespersen SN; Kallehauge JF; Lindegaard JC; Tanderup K
Acta Oncol; 2010 Oct; 49(7):978-83. PubMed ID: 20831485
[TBL] [Abstract][Full Text] [Related]
15. Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy?
Bae JM; Kim CK; Park JJ; Park BK
Abdom Radiol (NY); 2016 Aug; 41(8):1604-10. PubMed ID: 27056747
[TBL] [Abstract][Full Text] [Related]
16. Should We Cease to Perform Salvage Hysterectomy After Chemoradiation and Brachytherapy in Locally Advanced Cervical Cancer?
Gosset M; Chargari C; Bentivegna E; Leary A; Genestie C; Maulard A; Morice P; Gouy S
Anticancer Res; 2019 Jun; 39(6):2919-2926. PubMed ID: 31177130
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted magnetic resonance imaging during radiotherapy of locally advanced cervical cancer--treatment response assessment using different segmentation methods.
Haack S; Tanderup K; Kallehauge JF; Mohamed SM; Lindegaard JC; Pedersen EM; Jespersen SN
Acta Oncol; 2015; 54(9):1535-42. PubMed ID: 26217984
[TBL] [Abstract][Full Text] [Related]
19. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy.
Onal C; Erbay G; Guler OC
J Magn Reson Imaging; 2016 Oct; 44(4):1010-9. PubMed ID: 26919800
[TBL] [Abstract][Full Text] [Related]
20. Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer.
Morice P; Rouanet P; Rey A; Romestaing P; Houvenaeghel G; Boulanger JC; Leveque J; Cowen D; Mathevet P; Malhaire JP; Magnin G; Fondrinier E; Berille J; Haie-Meder C
Oncologist; 2012; 17(1):64-71. PubMed ID: 22234626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
